7th Oct 2011 12:43
Company Epistem Plc
TIDM EHP.L (AIM)
Headline Directors' Shareholdings
Released 7th October 2011
Epistem Holdings Plc ("Epistem" or the "Company")
Directors' Shareholdings
Epistem today provides an update regarding the Company's share investment plan, details of which were announced on 13 July 2009.
As a result of the subscription for Partnership Shares and the award of Matching Shares, the executive Directors each increased their beneficial interests in the Company by 291 ordinary shares of 1.5p each. These shares were acquired on 29 July 2011, 5 September 2011 and 21 September 2011 at prices of 385p, 378p and 375p respectively.
Following these transactions, the current beneficial interests of the executive Directors are set out below:
Matthew Walls 8,668 (0.11%)
Dr Catherine Booth 983,023 (12.39%)
Dr Jeffrey Moore 15,348 (0.19%)
John Rylands 192,921 (2.43%)
For further details please contact:
Epistem Plc
Matthew Walls, CEO +44 161 606 7258
John Rylands, Finance Director +44 161 606 7244
Peel Hunt LLP
James Steel / Vijay Barathan +44 20 7418 8900
Related Shares:
Genedrive